earnings
BI
NASDAQ · BIOA
BioAge Labs, Inc.
Healthcare · Biotechnology
$7.75
Up+$0.08 (+1.00%)
Updated Sep 17, 2026, 3:26 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 458.05M
- P/E ratio
- -6.04
- Dividend yield
- 0.00%
- 52-week range
- $8.02 – $25.96
- Volume
- 715.82K
- Avg. volume
- 403.63K
Price performance
BIOA price history
1M range · 20 trading sessions · Daily adjusted prices
BIOA closed at $7.75 after 20 trading sessions, down 27.91% for the selected period.
- Last close
- $7.75
- Period change
- -27.91%
- Period low
- $7.75
- Period high
- $10.75
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $8.21 | $8.275 | $7.62 | $7.75 | 715.82K |
| Sep 15, 2026 | $8.48 | $8.50 | $8.02 | $8.18 | 643.57K |
| Sep 14, 2026 | $8.52 | $8.635 | $8.39 | $8.48 | 563.39K |
| Sep 11, 2026 | $8.71 | $8.89 | $8.28 | $8.49 | 672.08K |
| Sep 10, 2026 | $9.07 | $9.07 | $8.60 | $8.65 | 492.87K |
| Sep 9, 2026 | $9.38 | $9.40 | $9.02 | $9.17 | 488.35K |
| Sep 8, 2026 | $9.60 | $9.645 | $9.3239 | $9.395 | 388.07K |
| Sep 4, 2026 | $9.39 | $9.76 | $9.39 | $9.59 | 314.85K |
| Sep 3, 2026 | $9.90 | $9.98 | $9.415 | $9.50 | 407.28K |
| Sep 2, 2026 | $9.59 | $10.05 | $9.425 | $9.73 | 541.26K |
| Sep 1, 2026 | $9.28 | $9.72 | $9.1501 | $9.52 | 605.31K |
| Aug 31, 2026 | $9.61 | $9.63 | $9.20 | $9.50 | 1.03M |
| Aug 28, 2026 | $10.06 | $10.25 | $9.595 | $9.65 | 452.19K |
| Aug 27, 2026 | $9.93 | $10.23 | $9.80 | $10.08 | 475.43K |
| Aug 26, 2026 | $10.03 | $10.03 | $9.76 | $9.84 | 504.28K |
| Aug 25, 2026 | $9.55 | $10.13 | $9.55 | $10.11 | 499.33K |
| Aug 24, 2026 | $9.57 | $9.65 | $9.16 | $9.38 | 661.58K |
| Aug 21, 2026 | $9.78 | $9.9164 | $9.48 | $9.48 | 453.45K |
| Aug 20, 2026 | $10.64 | $10.725 | $9.63 | $9.69 | 776.79K |
| Aug 19, 2026 | $10.69 | $10.88 | $10.38 | $10.75 | 412.25K |
Latest BIOA news
The latest Smart Investors Daily articles mentioning BIOA.
Stock researchCompany · Financials
Loading stock research…